Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 July, 2020 07:37 IST
Dr Reddy's announces completion of USFDA audit of formulation facility
Source: IRIS | 16 Jan, 2019, 10.15AM
Comments  |  Post Comment

Dr Reddy's Laboratories announced that audit of the company's Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the USFDA, has been completed on January 15, 2019. The company has been issued a Form 483 with 4 observations.

The stock had underperformed the market over the past one month till Jan. 15, 2019, falling 0.37% compared with the Sensex's 0.99% rise. It outperformed the market in past one quarter, gaining 5.37% as against 4.17% rise in the Sensex.

Shares of the company declined Rs 56.95, or 2.2%, to trade at Rs 2,535.00. The total volume of shares traded was 0 at the BSE (9.02 a.m., Wednesday).

Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Security Code type    into this box
Company Update
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer